Braveheart Bio
Biotechnology Research in United States
Overview
Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Its lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity.
EMPLOYEES
51-200 employees
FOUNDED
—
HQ
San Francisco, CA
TYPE
Public Company
Location
- Street
- One Letterman Drive
- City
- San Francisco
- Region
- CA
- Postal code
- 941129
- Country
- United States
Email patterns
See email patterns for Braveheart Bio
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
braveheart.bio is the website of Braveheart Bio.
What is the industry of the company?
Braveheart Bio (braveheart.bio) is in the Biotechnology Research industry.
How many employees does the company have?
Braveheart Bio (braveheart.bio) has 51-200 employees.
What is the company type?
The company type of Braveheart Bio (braveheart.bio) is Public Company.
Where is the company headquartered?
Braveheart Bio (braveheart.bio) is headquartered in San Francisco, CA.
What is the address of the company?
The address of Braveheart Bio (braveheart.bio) is One Letterman Drive, San Francisco, CA, 941129, United States.
What are the social media accounts of the company?
The social media account of Braveheart Bio (braveheart.bio) is LinkedIn.
Social media